Taken together, these observations suggest that increased levels of TEX CD8+ TILs in patients with BC cannot necessarily be accounted for by increased tumor mutation burden, although we do not discount the possibility that TEX CD8+ TILs may be neoantigen specific. This evidence concerns the gene CD8A and neoplasm.